The largest offering in history—Anthropic's IPO, which plans to raise up to $100 billion on the Nasdaq—has hit a valuation negotiation: institutional investors consider the target of $1.5 trillion too high and are discussing a discount to $1–1.25 trillion, while the deal decision is effectively frozen pending October revenue figures that were not disclosed in the S-1 filing amendment.

image
image
image

What happened

Potential investors in Anthropic's IPO have declared the target valuation of $1.5 trillion to be too high: one of them called this level a "stretch" and proposed a price corridor of $1–1.25 trillion, while another allows for a reduction to $1 trillion or a decrease in the issuance volume to raise approximately $80 billion instead of the discussed $100 billion. Pressure intensified after the Nasdaq fell more than 5% in the session on November 5, 2026—its worst drop in 19 months. In the S-1 filing amendment dated November 2, 2026, the line for October revenue was left blank, and the market is waiting for this figure to judge whether growth has recovered after a slowdown. The company intends to conduct a roadshow on the Nasdaq in the week of November 16 under the ticker ANT: if a price range is not submitted by this deadline, the listing will likely be postponed.

Context

Anthropic's registration documentation already shows the scale and cost of its expansion: revenue for the first nine months of 2026 reached $33.2 billion, representing a 1206% year-over-year increase, although the massive percentage largely reflects a low-base effect. The net loss of $104 billion for the same period in the report is attributed mainly to accounting adjustments for financial instruments, rather than operating expenses. Simultaneously, the company has legally fixed obligations of approximately $895.4 billion for compute and infrastructure, formalizing its bet on scaling compute. The stock market debut is taking place against the backdrop of US midterm elections, where Democrats won, and legislative initiatives in several states restricting data center construction; institutional investors are currently in a "buyers' strike" mode—suspending purchases of expensive stocks until verifiable data appears.

Why this matters for the industry

For the AI industry, the Anthropic deal is a valuation benchmark: if the largest offering in history goes out with a discount or is postponed, a reassessment of multiples will become entrenched for all AI companies and infrastructure providers. Revaluation has already begun—CoreWeave, Nebius, and IREN have lost more than 10% of their market capitalization, and the cooling of institutional capital is affecting term sheets for private AI companies. Capital has shifted from growth rates to their quality: discounts are being demanded even from companies with extremely fast revenue growth. Political risk surrounding data centers adds a premium to the cost of capital for compute: with fixed contractual obligations, the next frontier training runs become dependent on the financial success of the IPO, and Anthropic's public status will add transparency to the real economy of frontier development. For startups, this marks the end of "narrative-based valuation," and the flip side of the cooling—cheaper talent and growing demand for efficiency—creates entry points for new teams.

Why this matters for users

Users and developers of Claude do not need to change anything: according to sources, IPO dynamics do not entail changes in the product or API prices, so there is no need to rewrite the roadmap. For those following the deal, the point of observation is the next S-1 amendment: if it includes a price range and October revenue confirming the recovery of growth, the listing may proceed at the upper limit; if the range is not submitted by the roadshow—expect a postponement, along with a shift in the timing of capital inflows to the sector. A separate lesson for market observers: in the current mode, a buyer can obtain a discount even from a company with record revenue growth rates—AI sector valuations are no longer growing solely on narrative.

What is still unknown / limitations

The main indicator of the deal—October revenue—is not disclosed in the S-1 amendment dated November 2, 2026, so conclusions about the recovery of growth after a slowdown cannot yet be verified; the disclosure also lacks monthly dynamics, and the extreme growth rate is largely explained by a low base. The net loss for nine months is a noisy metric: based on available data, it is impossible to separate operating expenses from accounting revaluations of financial instruments. A price range has not been submitted, so both the size of the discount and the actual execution of the listing on schedule remain hypotheses. Furthermore, available materials do not contain data on how the raised funds will affect the trajectory of model capabilities: a direct link between "IPO funds—growth of model capabilities" is not confirmed by sources.

Sources

Author

Look at AI, editorial team